Cargando…

Effect of a tumour-derived lipid-mobilising factor on glucose and lipid metabolism in vivo

Treatment of ex-breeder male NMRI mice with lipid mobilising factor isolated from the urine of cachectic cancer patients, caused a significant increase in glucose oxidation to CO(2,) compared with control mice receiving phosphate buffered saline. Glucose utilisation by various tissues was determined...

Descripción completa

Detalles Bibliográficos
Autores principales:	Russell, S T, Tisdale, M J
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2002
Materias:	Experimental Therapeutics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376149/ https://www.ncbi.nlm.nih.gov/pubmed/12189560 http://dx.doi.org/10.1038/sj.bjc.6600493

Ejemplares similares

Role of lipid-mobilising factor (LMF) in protecting tumour cells from oxidative damage
por: Sanders, P M, et al.
Publicado: (2004)

Role of β3-adrenergic receptors in the action of a tumour lipid mobilizing factor
por: Russell, S T, et al.
Publicado: (2002)

Expression of uncoupling proteins-1, -2 and -3 mRNA is induced by an adenocarcinoma-derived lipid-mobilizing factor
por: Bing, C, et al.
Publicado: (2002)

Lipid mobilising factors specifically associated with cancer cachexia.
por: Beck, S. A., et al.
Publicado: (1991)

Induction of proteasome expression in skeletal muscle is attenuated by inhibitors of NF-κB activation
por: Wyke, S M, et al.
Publicado: (2004)

Increased expression of the ubiquitin – proteasome pathway in murine myotubes by proteolysis-inducing factor (PIF) is associated with activation of the transcription factor NF-κB
por: Whitehouse, A S, et al.
Publicado: (2003)

Effect of the lipid-lowering agent bezafibrate on tumour growth rate in vivo.
por: Mulligan, H. D., et al.
Publicado: (1991)

Signal transduction pathways involved in proteolysis-inducing factor induced proteasome expression in murine myotubes
por: Smith, H J, et al.
Publicado: (2003)

Effects of tumour acidification with glucose+MIBG on the spontaneous metastatic potential of two murine cell lines
por: Kalliomäki, T, et al.
Publicado: (2004)

Role of protein kinase C and NF-κB in proteolysis-inducing factor-induced proteasome expression in C(2)C(12) myotubes
por: Smith, H J, et al.
Publicado: (2004)

The role of zinc in the anti-tumour and anti-cachectic activity of D-myo-inositol 1,2,6-triphosphate
por: Russell, S T, et al.
Publicado: (2010)

In vivo evolution of tumour cells after the generation of double-strand DNA breaks
por: Mekid, H, et al.
Publicado: (2003)

Effect of eicosapentaenoic acid, protein and amino acids on protein synthesis and degradation in skeletal muscle of cachectic mice
por: Smith, H J, et al.
Publicado: (2004)

Pimonidazole binding in C6 rat brain glioma: relation with lipid droplet detection
por: Zoula, S, et al.
Publicado: (2003)

Development of an in-vitro model system to investigate the mechanism of muscle protein catabolism induced by proteolysis-inducing factor
por: Gomes-Marcondes, M C C, et al.
Publicado: (2002)

The anticancer drug mithramycin A sensitises tumour cells to apoptosis induced by tumour necrosis factor (TNF)
por: Duverger, V, et al.
Publicado: (2004)

Porphyrin accumulation induced by 5-aminolaevulinic acid esters in tumour cells growing in vitro and in vivo
por: Tunstall, R G, et al.
Publicado: (2002)

Dietary induction of NQO1 increases the antitumour activity of mitomycin C in human colon tumours in vivo
por: Begleiter, A, et al.
Publicado: (2004)

Adipose atrophy in cancer cachexia: morphologic and molecular analysis of adipose tissue in tumour-bearing mice
por: Bing, C, et al.
Publicado: (2006)

Antitumour 2-(4-aminophenyl)benzothiazoles generate DNA adducts in sensitive tumour cells in vitro and in vivo
por: Leong, C-O, et al.
Publicado: (2003)

Metabolic sensitivity of pancreatic tumour cell apoptosis to glycogen phosphorylase inhibitor treatment
por: Lee, W-N P, et al.
Publicado: (2004)

Induction of protein catabolism in myotubes by 15(S)-hydroxyeicosatetraenoic acid through increased expression of the ubiquitin–proteasome pathway
por: Whitehouse, A S, et al.
Publicado: (2003)

Micronuclei to detect in vivo chemotherapy damage in a p53 mutated solid tumour
por: Driessens, G, et al.
Publicado: (2003)

In vitro selectivity, in vivo biodistribution and tumour uptake of annexin V radiolabelled with a positron emitting radioisotope
por: Collingridge, D R, et al.
Publicado: (2003)

Role of glucose and ketone bodies in the metabolic control of experimental brain cancer
por: Seyfried, T N, et al.
Publicado: (2003)

Effect of a tumour-produced lipid-mobilizing factor on protein synthesis and degradation
por: Islam-Ali, B S, et al.
Publicado: (2001)

Combined hyperthermia and chlorophyll-based photodynamic therapy: tumour growth and metabolic microenvironment
por: Kelleher, D K, et al.
Publicado: (2003)

In vivo evaluation of [(18)F]fluoroetanidazole as a new marker for imaging tumour hypoxia with positron emission tomography
por: Barthel, H, et al.
Publicado: (2004)

Inhibition of the alpha-ν integrins with a cyclic RGD peptide impairs angiogenesis, growth and metastasis of solid tumours in vivo
por: Buerkle, M A, et al.
Publicado: (2002)

Orthogonal polarisation spectral imaging as a new tool for the assessment of antivascular tumour treatment in vivo: a validation study
por: Pahernik, S, et al.
Publicado: (2002)

A novel combretastatin A-4 derivative, AC7700, strongly stanches tumour blood flow and inhibits growth of tumours developing in various tissues and organs
por: Hori, K, et al.
Publicado: (2002)

Preferential expression of hPGFS in primary SCCHN and tumour cell lines derived from respiratory and digestive organs
por: Li, S, et al.
Publicado: (2004)

Effect of manipulation of primary tumour vascularity on metastasis in an adenocarcinoma model
por: Davies, M M, et al.
Publicado: (2002)

Porphyrin synthesis from ALA derivatives for photodynamic therapy. In vitro and in vivo studies
por: Perotti, C, et al.
Publicado: (2004)

Lipid Deposition and Mobilisation in Atlantic Salmon Adipocytes
por: Bou, Marta, et al.
Publicado: (2020)

3-Bromophenyl 6-acetoxymethyl-2-oxo-2H-1-benzopyran-3-carboxylate inhibits cancer cell invasion in vitro and tumour growth in vivo
por: Kempen, I, et al.
Publicado: (2003)

The role of glucocorticoids in the induction of zinc-α(2)-glycoprotein expression in adipose tissue in cancer cachexia
por: Russell, S T, et al.
Publicado: (2005)

Effects of overexpression of ephrin-B2 on tumour growth in human colorectal cancer
por: Liu, W, et al.
Publicado: (2004)

Influence of epidermal growth factor receptor (EGFR), p53 and intrinsic MAP kinase pathway status of tumour cells on the antiproliferative effect of ZD1839 (‘Iressa’)
por: Magné, N, et al.
Publicado: (2002)

Melanoma cell migration is upregulated by tumour necrosis factor-α and suppressed by α-melanocyte-stimulating hormone
por: Zhu, N, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_qds2k69e2h3vd416gi8ma0hsad